Hereditary Retinal Diseases Introduction and update - - PowerPoint PPT Presentation

hereditary retinal diseases introduction and update
SMART_READER_LITE
LIVE PREVIEW

Hereditary Retinal Diseases Introduction and update - - PowerPoint PPT Presentation

Hereditary Retinal Diseases Introduction and update !"#"$%&'()*+(),-./&01& 2)3,%&'4)+"%#"565&.7&8"+("9%,&


slide-1
SLIDE 1

Hereditary Retinal Diseases Introduction and update

!"#"$%&'()*+(),-./&01& 2)3,%&'4)+"%#"565&.7&8"+("9%,& 8"+("9%,&'6%6)&:,"*);5"6$&<.##)9)&.7&=>?%,&8)@"+",)&& A55"56%,6&B;.7)55.;&",&6()&'>;9);$&0)4%;6?),6& &

slide-2
SLIDE 2

Objectives

  • 2)*")C&56>@$&6..#5&7.;&();)@"6%;$&;)3,%#&@"5)%5)5&
  • 2)*")C&"?"6%6.;5&.7&A280&
  • 2)*")C&4.6),3%#&6;)%6?),6&7.;&();)@"6%;$&;)3,%#&@"5)%5)5&
slide-3
SLIDE 3

Inherited retinal diseases

  • <.?4;"5)&%&C"@)&;%,9)&.7&9),)3+%##$&%,@&4(),.6$4"+%##$&

()6);.9),).>5&@"5)%5)5&6(%6&5(%;)&",&+.??.,&4;.9;)55"*)&#.55&.7& 4(.6.;)+)46.;&7>,+3.,&%++.?4%,")@&D$&*"5>%#&#.55E&

  • 8%$&.++>;&",&"5.#%3.,&.;&%5&4%;6&.7&%&?>#3F5$56)?"+&+.,@"3.,&
slide-4
SLIDE 4

Cone Dysfunction Syndromes

  • Achromatopsia
  • Oligocone Trichromacy
  • Blue cone monochromacy
  • Enhanced S-cone syndrome

Rod Dysfunction Syndromes

  • Congenital Stationary Night Blindness

X-Linked Complete CSNB Incomplete CSNB Autosomal Dominant RHO,GNAT1, PDE6B Autosomal Recessive GRM6, TRPM1, LRIT1

  • Fundus albipunctatus (RDH5)
  • Oguchi Disease (ARR, GRK1)

X-linked Retinoschisis Fleck Dystrophies

  • Benign Familial Fleck
  • Retinitis Punctata Albescens
  • Alport

Retinal Degenerations/Dystrophies

Retinitis Pigmentosa

Nonsyndromic RP

  • Rod-cone dystrophies
  • Cone-rod dystrophies
  • Cone dystrophies

Leber’s Congential Amaurosis SECORD/Juvenile RP X-Linked RP AR RP AD RP

Syndromic RP

Ciliopathies

  • Usher's syndrome
  • Bardet – Beidl Syndrome
  • Joubert Syndrome
  • Senior Loken Syndrome
  • Alstrom Syndrome

Mitochondrial (Kearns-Sayre) Peroxisomal (Zellweger, Refsum)

Choroidal Degenerations

Choroderemia Gyrate Atrophy Bietti Crystalline Dystrophy Late Onset Retinal Dystrophy

Macular Degenerations/ Dystrophies

North Carolina Macular Dystrophy Isolated Foveal Hypoplasia Albinism

  • Oculocutaneous

Albinism

  • Ocular Albinism

ABCA4 Spectrum Stargardt/Fundus Flavimaculatus

  • Macular Dysfunction
  • Peripheral Cone
  • Peripheral Rod/Cone

BEST1 Spectrum

  • AD Best Macular Dystrophy
  • Multifocal Vitelliform
  • AOFPED
  • AR Best Macular Dystrophy
  • ADVIRC

PRPH2 Spectrum

  • Pattern Dystrophy
  • Central Areolar Choroidal

Dys. EFEMP1 Spectrum Dominant Drusen Doyne’s Honeycomb Dystrophy Malattia Levintenese Sorsby Macular Dystrophy Occult Macular Dystrophy

A@%46)@&%,@&?.@"G)@&C"6(&4);?"55".,&.7&8%;-&B),,)5"/&80/&B(0&

slide-5
SLIDE 5

The Spectrum of Retinal Degenerations RP

!"#$%&'(")$*+

  • +A0/&A2/&H!/&8"6.+(.,@;"%#&

,$-&."*+

  • &8%+>#%&
  • &B);"+),6;%#&
  • &B.56);".;&B.#)&
  • &8"@F4);"4();$&
  • &<.,+),6;"+&
  • &B%,&2)3,%&

/$"$0*+

  • &!"#$%&
  • &'()*%&
  • &+#,&
  • &'+'#$&
  • &+'-+&
  • &+')*.&

1-$+.2+3"0$'*+

  • &I&J&$)%;&K&!<A&
  • &JFL&$)%;5&K&'M<120&
  • &LFJN&$)%;5&K&H!2B&
  • &ONFPN&$)%;5&K&A2&.;&A0&2B&
  • &Q&LL&$)%;5&F&A>6."??>,)&

4(5$%*+

  • &R"6;).;)3,%#&
  • &2)3,%#&
  • &2BM&
  • &<(.;".;)3,%#&
  • &<(.;."@&

67")8."(9+4.00*+

  • &2.@F<.,)&@$56;.4($&
  • &<.,)F2.@&0$56;.4($&
  • &<.,)&0$56;.4($&

&

:5";%.<&)*+

  • &:5();&'$,@;.?)&
  • &S%;@)6FS)"@#&
  • &T.>D);6&'$,@;.?)&
  • &'),".;F!.-),&
  • &2)75>?&
  • &A#56;.?&

3%-("$99$0*+

  • &!$5.5.?)5&
  • &B);.U"5.?)5&
  • &8"6.+(.,@;"%&
  • &<"#">?&
  • &<),6;".#)&&&&&&&

2)4;.@>+)@&C"6(&4);?"55".,&.7&8%;-&B),,)5"/&80/&B(0&

slide-6
SLIDE 6

How do we evaluate hereditary retinal diseases?

  • M2V&
  • 1<W&
  • R"5>%#&G)#@&
  • A>6.X>.;)5+),+)&
  • Y#>.;)5+)",&%,9".9;%?&
  • <.#.;&4(.6.5&
  • Y%?"#$&("56.;$&
slide-7
SLIDE 7

Electroretinogram

  • M#)+6;"+%#&4.6),3%#&9),);%6)@&D$&6()&;)3,%&",&;)54.,5)&6.&%&+(%,9)&",&

"##>?",%3.,E&

  • 2)54.,5)&6.&X%5(&"5&%&5>??)@&%+3*"6$&.7&%##&;)3,%#&+)##5&%,@&+.,5"565&

.7&.*);#%44",9&4.5"3*)&%,@&,)9%3*)&+.?4.,),6&4.6),3%#5&6(%6& .;"9",%6)&7;.?&@"Z);),6&56%9)5&.7&;)3,%#&4;.+)55",9&

slide-8
SLIDE 8
slide-9
SLIDE 9
slide-10
SLIDE 10
slide-11
SLIDE 11

ERG equipment

slide-12
SLIDE 12
slide-13
SLIDE 13

Multifocal ERG

slide-14
SLIDE 14

Visual field

slide-15
SLIDE 15

Fundus photography and autofluorescence

slide-16
SLIDE 16
slide-17
SLIDE 17

OCT

slide-18
SLIDE 18

FA

slide-19
SLIDE 19

Color testing

slide-20
SLIDE 20

Family history taking

  • 0"@&%,$.,)&",&$.>;&7%?"#$&[D#..@&;)#%3*)5\&(%*)&*"5".,&4;.D#)?5&%6&

$.>,9&%9)]&

  • 16();&6(%,&+%6%;%+65&%,@^.;&&,))@",9&9#%55)5]&
slide-21
SLIDE 21

Macular degenerations and dystrophies: pitfalls and close calls

slide-22
SLIDE 22

Differentiating AMD from Macular dystrophies

  • _.&4%6(.9,.?.,"+&+#","+%#&+(%;%+6);"53+5&7.;&A80&
  • S;.%@&4(),.6$4"+&54)+6;>?&.7&A80&%++.>,65&7.;&.*);#%4&C"6(&

@$56;.4(")5&

  • Y#)+-5`0;>5),&
  • <(.;".;)3,%#&%6;.4($`V).9;%4("+&%6;.4($&
  • <_R&
  • 0"Z);),3%3.,&"5&"?4.;6%,6&D)+%>5)&.7&"?4#"+%3.,5&7.;&6()&4;.9,.5"5/&

9),)3+&+.>,5)##",9&%,@&4;)*),6%3*)&6();%4$&

slide-23
SLIDE 23
slide-24
SLIDE 24

A word about Drusen and Drusen-like lesions

=%70$"+ 69$)>0+ ?&'$99&2.%<+9$0&."0+

  • Y.+%#&@)4.5"65&.7&)U6;%+)##>#%;&

@)D;"5&

  • S)6C)),&D%5%#&#%?",%&.7&2BM&

%,@&S;>+(a5&?)?D;%,)&

  • <%;D.($@;%6)5/&b",+&%,@&%6&#)%56&

JOc&4;.6)",5&

  • Y>,@.5+.4$d&$)##.C"5(&,.@>#%;&

#)5".,&#.+%6)@&%6&6()&4.56);".;& 4.#)&

  • <>3+>#%;&
  • 2)3+>#%;&
  • <.##."@&
  • e,&6()&@))4);&;)3,%#&#%$);5&",&

4.56);".;&4.#)&

  • R%;"%D#)&",&5"b)/&5(%4)&%,@&

@"56;"D>3.,&

  • <%,&D)&",6);+.,,)+6)@&",&?"@F

4);"4();$&6.&7.;?&;)3+>#%;& 4%f);,&

  • 2.>,@/&$)##.C"5(&#)5".,&6(%6&

#..-5&#"-)&%,&)99&$.#-&

  • e,6),5)&($4);%>6.YA&
  • =$4.X>.;)5+),+)&.,&YA&
  • A++>?>#%3.,&.7&($4);;)X)+3*)&

?%6);"%#&D)6C)),&&6()& ,)>;.;)3,%&%,@&2BM&

slide-25
SLIDE 25

Patient # 1

  • gP&$E.E&?%#)&4;)5),65&7.;&)*%#>%3.,&.7&'6%;9%;@6&8%+>#%;&0$56;.4($&&
  • _.&*"5>%#&+.?4#%",65&&
  • B8=d&:#+);%3*)&+.#"35&5^4&+.#)+6.?$/&()%@%+()5/&%,)?"%/&,#&@")6&
  • Y1=Ud&A@.46)@&
  • 21'd&_)9%3*)&
slide-26
SLIDE 26

Exam

,&-#'+$5$++ 4$@+$5$+ ?&07(9+()7&'5++ ON^ON& ON^ON& !3A+ JP& JO& B,,+ h^h& h^h& 1"'$%&.%+0$-<$"'++ _.;?%#& _.;?%#& 1"'$%&.%+C&'%$.70+ _.&+)##& _.&+)##&

slide-27
SLIDE 27
slide-28
SLIDE 28
slide-29
SLIDE 29
slide-30
SLIDE 30
slide-31
SLIDE 31
slide-32
SLIDE 32
slide-33
SLIDE 33

Pattern dystrophy-PRPH2

  • A0&
  • B;)5),6&",&?"@#"7)&C"6(&?"#@&+),6;%#&*"5".,&

@"56>;D%,+)5&

  • S>f);X$&
  • 2)3+>#%;&
  • Y>,@>5&4>#*);>#),6>5&
  • B5)>@.F'6%;9%;@6&
  • Y#)+-5&",&6()&4.56);".;&4.#)&%,@&%;.>,@&*%5+>#%;&

%;+%@)5&

  • B;)+)@)@&D$&?%+>#%;&4%f);,&@$56;.4($&.;&

,.,54)+"G+&7.*)%#&+(%,9)5&

  • YAY&5(.C5&("9(#$&",+;)%5)@&%>6.YA/&C("+(&)*.#*)&

6.C%;@&+.,X>),6&%6;.4("+&%;)%5&%,@&5(.C5&#%;9);& b.,)&.7&@)+;)%5)@&YAY&5"9,%#&

slide-34
SLIDE 34

Pattern vs AMD

  • <.,7>5".,&D)+%>5)&
  • <#","+%##$&*"5"D#)&5"9,5&4;)5),3,9&",&?"@#"7)&%,@&*"5>%#&+.?4#%",5&?%$&?%,"7)56&

#%6);&&

  • ')+.,@%;$&+(%,9)5&5>+(&%5&<_R&.;&VA&
  • Y)%6>;)5&6(%6&()#4&@"Z);),3%6)&
  • 2)#%3*)#$&)%;#$&%9)&
  • B.5"3*)&7%?"#$&(U&
  • 8.;)&4;.,.>,+)@&%>6.YA&
  • B);"4();%#&;)3,%#&%D,.;?%#"3)5&C"6(&+.;;)54.,@",9&%D,.;?%#"3)5&ZM2V&
  • V),)3+&6)53,9&
slide-35
SLIDE 35

Patient # 2

  • gi&$E.E&7)?%#)&4;)5),65&7.;&)*%#>%3.,&.7&'6%;9%;@6&8%+>#%;&

0$56;.4($&&

  • _.&*"5>%#&+.?4#%",65/&)U+)46&5()&@.)5&,.6&#"-)&6.&@;"*)&%6&,"9(6&
  • B8=d&_)9%3*)&
  • Y1=Ud&_)9%3*)&
  • 21'd&_)9%3*)&
slide-36
SLIDE 36

Exam

,&-#'+$5$++ 4$@+$5$+ ?&07(9+()7&'5++ ON^OL& ON^gN& !3A+ Jg& JO& B,,+ h^h& h^h& 1"'$%&.%+0$-<$"'++ B.56);".;&4.#%;&+%6%;%+6& B.56);".;&4.#%;&+%6%;%+6& 1"'$%&.%+C&'%$.70+ _.&+)##& _.&+)##&

slide-37
SLIDE 37
slide-38
SLIDE 38
slide-39
SLIDE 39
slide-40
SLIDE 40
slide-41
SLIDE 41
slide-42
SLIDE 42
slide-43
SLIDE 43
slide-44
SLIDE 44
slide-45
SLIDE 45

Stargardt disease—ABCA4

  • A2&
  • Y";56&O&@)+%@)5&.7&#"7)&
  • B;.9;)55"*)&+),6;%#&*"5".,&#.55&
  • YAYd&$)##.C&X)+-&+.;;)54.,@&6.&",6),5)&

%>6.YA/&5.?)&X)+-5&5>;;.>,@)@&D$&(%#.&.7& ($4.%>6.YA&

  • 0%;-&+(.;."@&",&iNj&
  • 1<W&5(.C5&($4);;)X)+3*)&6("+-),",9&.7&2BM&
slide-46
SLIDE 46

AMD vs Stargardt

  • <.,7>5".,&D)+%>5)&.7&&
  • !%6)&%9)&.7&.,5)6&
  • W()&4;)5),+)&.7&$)##.C&X)+-5/&+(.;".;)3,%#&%6;.4($&%,@&;%;)#$&<_R8&
  • Y)%6>;)5&6(%6&()#4&@"Z);),3%6)&
  • Y#)+-5&%;)&?.;)&";;)9>#%;#$&5(%4)@&6(%,&@;>5),&
  • e,6),5)&%>6.YA&C"6(&5>;;.>,@",9&(%#.&.7&@)+;)%5)@&AY&
  • 0%;-&+(.;."@&
  • 8>6%3.,&",&AS<AP&&
slide-47
SLIDE 47

Patient # 3

  • hg&$E.E&7)?%#)&;)7);;)@&7.;&kX>"@l&",&6()&#)m&)$)&
  • _.3+)5&@)+#",)&",&RA&10&
  • B8=d&_.,+.,6;"D>6.;$&
  • B1=Ud&k,.&@"5)%5)&+%>5",9&*%;"%3.,5&",&20'l&
slide-48
SLIDE 48

Exam

,&-#'+$5$++ 4$@+$5$+ ?&07(9+()7&'5++ ON^iN& ON^PN& !3A+ JJ& JJ& B,,+ _^A& _^A& 1"'$%&.%+0$-<$"'++ _.;?%#& _.;?%#& 1"'$%&.%+C&'%$.70+ _.&+)##& _.&+)##&

slide-49
SLIDE 49
slide-50
SLIDE 50
slide-51
SLIDE 51
slide-52
SLIDE 52
slide-53
SLIDE 53
slide-54
SLIDE 54

AOFPED

  • 1,)&.7&6()&4%f);,&@$56;.4(")5&
  • 8"#@&&RA&#.55&.;&?)6%?.;4(.45"%&
  • S"#%6);%#&5?%##&;.>,@&$)##.CFC("6)&#)5".,5&",&6()&

7.*)%&C"6(.>6&@;>5),&

  • YAYd&($4);AY&
  • YAd&0.6F%,@F=%#.&.;&k5.#%;&)+#"45)l&&
  • 1<W&#)5".,5&D)6C)),&,)>;.;)3,%&%,@&2BM/&

%@*%,+)@&@"5)%5)&&4(.6.;)+)46.;5&%,@&2BM& D)+.?)&@"5;>46)@&

  • _.;?%#&.;&?"#@#$&%D,.;?%#&M1V&
  • V),)3+&+%>5)&",&?",.;"6$&.7&465&
slide-55
SLIDE 55

AOFPED vs AMD

  • <.,7>5".,&D)+%>5)&.7&
  • '?%##&;.>,@&$)##.C&C("6)&?%+>#%;&#)5".,&6(%6&?%$&D)&+.?4#"+%6)@&D$&<_R&
  • Y)%6>;)5&6(%6&()#4&@"Z);),3%3.,d&
  • R"6)##"7.;?&#)5".,&C"6(.>6&@;>5),&
  • 8%;-)@&%>6.YA&
  • !)5".,&+.;;)54.,@",9&6.&($4);;)X)+3*)&%++>?>#%3.,&%D.*)&6()&2BM&
slide-56
SLIDE 56

Take home points:

  • Y>,@.5+.4$/&%>6.YA/&1<W&%,@&)#)+6;.4($5".#.9$&%;)&)55),3%#&",&

%44;.%+(",9&4%3),65&C"6(&?%+>#%;&@$56;.4(")5&

  • ="56.;$&6%-",9d&
  • '4)+"G+&5$?46.?5&
  • Y%?"#$&("56.;$&

&

slide-57
SLIDE 57

Take home points:

  • Y>,@.5+.4$/&%>6.YA/&1<W&%,@&)#)+6;.4($5".#.9$&%;)&)55),3%#&",&

%44;.%+(",9&4%3),65&C"6(&?%+>#%;&@$56;.4(")5&

  • ="56.;$&6%-",9d&
  • '4)+"G+&5$?46.?5&
  • Y%?"#$&("56.;$&

&

slide-58
SLIDE 58

Fundus autofluorescence

  • W()&?.56&*%#>%D#)&@"Z);),3%3,9&6..#&6.&@"53,9>"5(&&@$56;.4(")5&7;.?&

)%+(&.6();&%,@&7;.?&A80&

  • e,@";)+6&;)X)+3.,&.7&?)6%D.#"+&+(%,9)5&%,@&#"4.7>5+",&%++>?>#%3.,&

%6&6()&#)*)#&.7&6()&2BM&

slide-59
SLIDE 59

Optical Coherence Tomography

  • '0F1<W&%##.C5&("9(F;)5.#>3.,&%,%#$5"5&.7&6()&%,%6.?"+%#&#.+%3.,&.7&

6()&@)4.5"65&%,@^.;&X)+-5&",&&.;&>,@);&6()&;)3,%&.;&B2M&

slide-60
SLIDE 60

Psychophysical and electrophysiological testing

  • ?7M2V&+%,&D)+.?)&%D,.;?%#&)%;#$&",&6()&+.>;5)&.7&6()&@"5)%5)&
  • !"?"6)@&*%#>)&",&@"Z);),3%#&@"%9,.5"5&
  • ZM2V&+%,&D)+.?)&4;.9;)55"*)#$&%D,.;?%#&",&5.?)&@"5)%5)5&C"6(&3?)&
  • M1V&;)X)+65&4%,;)3,%#&7>,+3.,&.7&2BM&
slide-61
SLIDE 61

Genetic testing

  • A80&"5&?>#37%+6.;"%#&@"5)%5)&C"6(&5)*);%#&9),)3+&%,@&),*";.,?),6%#&

7%+6.;5&

  • S)C%;)&.7&4(),.6$4"+&()6);.9),)"6$&
  • M54)+"%##$&()#47>#&",&4%3),6&C"6(&)%;#$&%,@&),@F56%9)&@"5)%5)&
  • A"@5&",&4;.*"@",9&%&+#","+%#&4;.9,.5"5&&
slide-62
SLIDE 62

Genetic Testing

  • V),)3+&6)565&%;)&6)565&.,&D#..@&%,@&.6();&355>)&6.&G,@&9),)3+&

@"5.;@);5&

  • Y",@",9&9),)3+&@"5)%5)5&",&>,D.;,&D%D")5&
  • Y",@",9&.>6&"7&4).4#)&+%;;$&%&9),)&7.;&%&@"5)%5)&%,@&?"9(6&4%55&"6&.,&6.&6()";&

+("#@;),&

  • '+;)),",9&)?D;$.5&7.;&@"5)%5)&
  • W)53,9&7.;&9),)3+&@"5)%5)5&",&%@>#65&D)7.;)&6()$&+%>5)&5$?46.?5&
  • 8%-",9&%&@"%9,.5"5&",&%&4);5.,&C(.&(%5&@"5)%5)&5$?46.?5&
  • Y"9>;",9&.>6&6()&6$4)&.;&@.5)&.7&%&?)@"+",)&6(%6&"5&D)56&7.;&%&+);6%",&4);5.,&
slide-63
SLIDE 63
  • B).4#)&(%*)&?%,$&@"Z);),6&;)%5.,5&7.;&D)",9&6)56)@&.;&,.6&D)",9&

6)56)@E&

  • e?4.;6%,6&6.&-,.C&C()6();&%&@"5)%5)&+%,&D)&4;)*),6)@&.;&6;)%6)@&"7&%&

6)56&"5&4.5"3*)E&e,&5.?)&+%5)5/&6();)&"5&,.&6;)%6?),6E&&

  • W)56&;)5>#65&?"9(6&()#4&%&4);5.,&?%-)&#"7)&@)+"5".,5/&5>+(&%5&7%?"#$&

4#%,,",9&.;&",5>;%,+)&+.*);%9)E&&

  • A&9),)3+&+.>,5)#.;&+%,&4;.*"@)&",7.;?%3.,&%D.>6&6()&4;.5&%,@&+.,5&

.7&6)53,9&

slide-64
SLIDE 64
slide-65
SLIDE 65

Gene Therapy - Delivery

LN&K&PLN&n!&

++++++++++++++++++++++++++ '>D;)3,%#& e,6;%*"6;)%#&

LN&n!&

slide-66
SLIDE 66

A&B(%5)&e^ee%&0.5)&M5+%#%3.,&'%7)6$&'6>@$&.7&'>D;)3,%##$&e,o)+6)@& 'A2POOPLc/&A@?","56);)@&6.&B%3),65&C"6(&'6%;9%;@6&8%+>#%;& 0)9),);%3.,&

:D."0.%*++

  • 1U7.;@&S".?)@"+%&:p&^&'%,.G&

A%&<(%5+!"C$08-('.%0d&&

  • 0"+-&q)#)D);&80/&T.5)&'%()#&80&

=$0&-"*&&&&

  • B(%5)&e^ee%&@.5)&)5+%#%3.,&56>@$&

:&'$0*+ ++

  • <%5)$&M$)&e,536>6)&
  • <),6;)&=.54"6%#");&_%3.,%#)&@a14(6(%#?.#.9")&@)5&r>",b)FR",965&

?$)'.%*&&&

  • ,.,F4;"?%6)&#),3*";%#&*)+6.;&D%5)@&.,&MeAR&

=$9&C$%5*&&&

  • '>D;)3,%#&",o)+3.,&

2)4;.@>+)@&C"6(&4);?"55".,&.7&8%;-&B),,)5"/&80/&B(0&

slide-67
SLIDE 67

SAR422459&

A%..2+.2+E.")$D'+&"+1F)(GHIH+<.70$+JK."-+$'+(9L+MNNOP+ +

  • '>D;)3,%#&@)#"*);$&6;%,57)+6)@&LFONj&.7&4(.6.;)+)46.;5&
  • ;)@>+)@&%++>?>#%3.,&.7&AOM&

:(2$'5IQ%("02$)8."+:'7;&$0+&"+R."H#7<("+A%&<('$0+JS&"9$5+$'+(9L+MNTUP+ +

  • 8","?%#&",X%??%3.,&
  • !.C&;"5-&7.;&",5);3.,%#&?>6%9),)5"5&

S(0$;+."+VW7&"$+!"2$)8.70+1"$<&(+?&%70+JV!1?P+ +

  • q"#@F6$4)&*";>5&+%>5)5&6;%,5"),6&%,)?"%&",&(.;5)5/&,.,F4%6(.9),"+&",&

(>?%,5&

  • 'A2POOPLc&*)+6.;&+.,6%",5&IJNj&.7&.;"9",%#&*";%#&9),.?)&
  • _.,F;)4#"+%3,9/&D>6&@.)5&",6)9;%6)&

Vector construct

slide-68
SLIDE 68

I&

&&& & &&& &

SAR422459 – Study Design

s^F<.(.;6&P& ,tg&& <.(.;6&J&s&O&&,th& <.(.;6&g& ,tg& <.(.;6&L& _tg&&

&!.C)56&

&8)@& &="9()56&

8W0& 0'8S&2)*")C&

0.5%9)&

STOP STOP STOP STOP

gh&B%3),65&W.6%#&

STOP

R%& ION^ONN& ION^ONN& ION^JNN& B(.&gEN&M2V& IhLnR& IucnR& IcOnR&

<.(.;6&h& _tOP&&

QON^ONN&

STOP

v4;.9;)55".,&

slide-69
SLIDE 69

I&

&&& & &&& &

SAR422459 – Study Design

s^F<.(.;6&P& ,tP&& <.(.;6&J&s&O&&,ti& <.(.;6&g& ,tP& <.(.;6&L& _th&&

&!.C)56&

&8)@& &="9()56&

8W0& 0'8S&2)*")C&

0.5%9)&

STOP STOP STOP STOP

Og^gh&B%3),65&W;)%6)@&6.&0%6)&

R%& ION^ONN& ION^ONN& ION^JNN& B(.&gEN&M2V& IhLnR& IucnR& IcOnR&

<.(.;6&h& _tOP&&

! ! ! ! ! ! !

STOP

! ! ! ! ! ! ! ! ! !! ! ! ! ! !

QON^ONN&

v4;.9;)55".,&

! !

slide-70
SLIDE 70
slide-71
SLIDE 71

Bibliography

  • _.;?%#&2)3,%#&A,%6.?$&%,@&S%5"+&B%6(.#.9"+&A44)%;%,+)5E&

(f4d^^+#","+%#9%6)E+.?^,.;?%#F;)3,%#F%,%6.?$F%,@FD%5"+F 4%6(.#.9"+F%44)%;%,+)5^&Nc^NL^ONJL&

  • '%-5),5&_EWE8E/&)6&%#E&8%+>#%;&@$56;.4(")5&?"?"+-",9&%9)F;)#%6)@&

?%+>#%;&@)9),);%3.,5E&B;.9;)55&",&2)3,%&%,@&M$)&2)5)%;+(E&ONNJPw& gcd&OgFLuE&

  • W5>"&eE/&)6&%#E&ONNuE&A&B;%+3+%#&A44;.%+(&6.&2)3,%#&0$56;.4(")5E&

2)3,%#&B($5"+"%,E&A4;"#&ONNu&

  • 2..5",9&'E/&)6&%#E&8>6%3.,5&",&8Y'0i/&M,+.@",9&%&!$5.5.?%#&

8)?D;%,)&B;.6)",/&A;)&A55.+"%6)@&C"6(&_.,5$,@;.?"+&A>6.5.?%#& 2)+)55"*)&8%+>#%;&0$56;.4($E&14(6(%#?.#.9$&ONJLwJOOdJuNFJuc&